You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Chronic Urticaria Or Hives Drug Market Study 2016-2026, by Segment (GDC-0853, GSK-2646264, … …), by Market (Clinic, Hospital, … …), by Company (AstraZeneca Plc, Biofrontera AG, … …)

Summary

The global Chronic Urticaria Or Hives Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Clinic
Hospital
Others
Company Coverage (Sales data, Main Products & Services etc.):
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Chronic Urticaria Or Hives Drug Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Chronic Urticaria Or Hives Drug Market by Type
2.1 By Type
2.1.1 GDC-0853
2.1.2 GSK-2646264
2.1.3 BF-Derm-1
2.1.4 Bilastine
2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 AstraZeneca Plc (Company Profile, Sales Data etc.)
5.2 Biofrontera AG (Company Profile, Sales Data etc.)
5.3 ELORAC, Inc. (Company Profile, Sales Data etc.)
5.4 Faes Farma, SA (Company Profile, Sales Data etc.)
5.5 Genentech, Inc. (Company Profile, Sales Data etc.)
5.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
5.7 J Uriach Y Compania, S.A. (Company Profile, Sales Data etc.)
5.8 Mabtech Limited (Company Profile, Sales Data etc.)
5.9 Merck & Co., Inc. (Company Profile, Sales Data etc.)
5.10 Mycenax Biotech Inc. (Company Profile, Sales Data etc.)
5.11 Novartis AG (Company Profile, Sales Data etc.)
5.12 Panacea Biotec Limited (Company Profile, Sales Data etc.)
6 Conclusion